Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a publicly traded Healthcare sector company. As of May 21, 2026, KMTS trades at $20.76 with a market cap of $1.14B and a P/E ratio of -4.05. KMTS moved +4.70% today. Year to date, KMTS is -14.99%; over the trailing twelve months it is -16.69%. Its 52-week range spans $13.25 to $30.00. Analyst consensus is strong buy with an average price target of $27.00. Rallies surfaces KMTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kestra Medical Earns 2026 USA TODAY Top Workplaces Award Based on Employee Feedback: Kestra Medical Technologies won the 2026 USA TODAY Top Workplaces award based on confidential team feedback from an Energage survey measuring engagement, alignment and organizational performance. The recognition highlights the company's culture strengths, which may bolster talent retention and drive product development in its wearable medical device operations.
| Metric | Value |
|---|---|
| Price | $20.76 |
| Market Cap | $1.14B |
| P/E Ratio | -4.05 |
| EPS | $-5.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.00 |
| 52-Week Low | $13.25 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $59.81M |
| Net Income | $-113.81M |
| Gross Margin | 40.48% |
6 analysts cover KMTS: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.00.